Covidien plc · Dublin Ireland · (NYSE: COV)

No longer one of the Tyco family, Covidien is making its own way in the vast medical supplies marketplace. Its former parent spun-off Covidien (previously known as Tyco Healthcare) as part of one of the biggest break ups in health care history. With some $10 billion in annual sales and a product offering that includes thousands of different brands (including Mallinckrodt and Kendall), Tyco's offspring is no baby. The giant supplies health care providers with everything from generic pharmaceuticals and disposable medical products to diagnostic imaging contrast agents and surgical devices. Covidien has global manufacturing operations and markets its products in more than 140 countries. To read the full description, subscribe now.

• C. R. Bard, Inc.
• Becton, Dickinson and Company
• Johnson & Johnson